Drawing for AGILE CLINICAL TRIALS TRAINING PROGRAM

USPTO serial 99826401

AGILE CLINICAL TRIALS TRAINING PROGRAM

Reviewed by CopyMark Law Group

Status 616
Filing date
Status date
Registration date
—
Examiner
AYALA, LOURDES
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AGILE CLINICAL TRIALS TRAINING PROGRAM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ping Wang

Ping Wang Kalos Athena Wang PLLC601 Pennsylvania Ave., NWSuite 900Washington, DC 20004

Goods and services

ClassDescriptionStatusFirst use
016Printed instruction sheets in the field of medical education; Printed pamphlets in the field of medical education; Printed publications, namely, brochures, booklets, and teaching materials in the field of medical educationACTIVE—
041Medical training and teaching; Providing continuing medical education courses; Continuing education services, namely, providing live and on-line continuing professional education seminars in the legal, medical, accounting, and real estate fieldsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 4, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2026NREVNOTICE OF REVIVAL - E-MAILED—
Nov 4, 2026PETGPETITION TO REVIVE-GRANTED—
Nov 4, 2026PROATEAS PETITION TO REVIVE RECEIVED—
Jul 30, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2026DOCKASSIGNED TO EXAMINER—
May 15, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
May 15, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 15, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance